Rodolphe Clerval

Rodolphe Clerval

Company: Coave Therapeutics

Job title: Chief Executive Officer


AAV-Ligand Conjugates for Improved Efficacy & Biodistribution in CNS 2:30 pm

AAV capsids from 1st and last generations limitations (efficiency and safety) are related to the nature of the capsid composition Chemical conjugation of AAV capsid alter dramatically the biology of AAV leading to improve bio distribution, transduction and immunological profile Chemical conjugation of AAV is a versatile and scalable new capsid technologyRead more

day: Day One: Track A PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.